Mandate

Vinge advises Irisity in connection with a directed new share issue

November 14, 2019 Capital Markets and Public M&A

Vinge is advising Irisity in connection with a directed new share issue of 4,094,000 shares whereby Irisity acquires approximately SEK 35 million.

A subscription price of SEK 8.55 has been determined through an accelerated book building procedure and constitutes a discount of approximately 7.1 per cent in comparison with the closing price of Irisity shares on Nasdaq First North on 13 November 2019. The issue proceeds, which are expected to be sufficient for Irisity to acquire a positive cashflow, are intended to strengthen the company’s financial stability and also be used to expand the organisation within the fields of research, development, marketing, sales and service. The resolution adopted by the board of directors concerning the new share issue is conditional upon the approval thereof at an extraordinary general meeting.

 

Vinge’s team mainly consisted of Anders Strid, Johanna Hamrefält and Lina André.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026